Investor directory

Palisade Bio

Palisade Bio is a clinical-stage biopharmaceutical company focused on developing innovative treatments for diseases with unmet medical needs. The company specializes in researching and advancing novel therapies, seeking to identify and acquire promising scientific assets and technologies that can offer meaningful benefits to patients. Its efforts center on addressing critical health challenges by leveraging proprietary research and development initiatives. Previously known as Seneca Biopharma, Palisade Bio has a commitment to enhancing patient care through the introduction of effective therapeutic options. The company's headquarters is located in Germantown, Maryland.

Top Stages

Acquisition
http://senecabio.com
https://crunchbase.com/organization/seneca-biopharma
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=7728881

Robert McRae

COO

1 past transactions

Leading BioSciences, Inc.

Acquisition in 2020
Leading BioSciences, Inc. (LBS) is a biopharmaceutical company that has developed a revolutionary medical platform based on the science of autodigestion. The company’s lead candidate (LB1148) is a therapeutic for severe sepsis, septic shock, and multi-organ failure. In addition, the company is developing a breath and blood diagnostic for early detection of acute shock and multi-organ failure. This therapy is part of an overall product design that includes the pharmaceutical formulation (LB1148) and the delivery device. To date, this new medical platform has produced 14 different products, therapies, and medical devices each with their own distinct patents and exclusive licenses.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.